Giles Richard Platford - 04 Nov 2026 Form 4 Insider Report for TAKEDA PHARMACEUTICAL CO LTD (TAK)

Reporting relationship: President, IBU
Issuer ticker: TAK
Reported as of: 04 Nov 2026
Net transaction value: -$1,162,395
SEC form: 4
Accepted by SEC: 05 Nov 2026, 15:54:34 UTC
Prior SEC filing: 12 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Kate Huleatt, by power of attorney, for Giles Platford

Filing notes and source

Key filing fact

Giles Richard Platford filed Form 4 for TAKEDA PHARMACEUTICAL CO LTD (TAK) on 05 Nov 2026.

Key facts

This page summarizes Giles Richard Platford's Form 4 filing for TAKEDA PHARMACEUTICAL CO LTD (TAK).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Nov 2026, 15:54.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0001977620 Primary reporting owner

Shares, units, or other non-derivative securities reported in this filing.

TAK transaction

Sale

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

Includes 10,032 ADS received upon the vesting of dividend equivalent units that were not included in the reporting person's previously filed Form 4.